CDMO Technology Domain

Advanced Formulation — Page 3

State-of-the-art dosage form engineering: polymeric sustained-release matrices, lipid-based drug delivery, enteric-coated capsules, and novel excipient selection.

49

dossiers

Cellular Longevity & Senolytics

Comparative Pharmacokinetics and Cellular Bioaccessibility of Senolytic Agents: Impact of Polymeric-Matrix Encapsulation

Orally administered senolytic compounds often suffer from poor pharmacokinetics, including low and variable bioavailability, rapid metabolism, pH-dependent dissolution, and limited cellular bioaccessibility.

Senotherapeutics Nanoparticles Drug Compounding Biological Availability

Custom Formulation Available

Need a Dossier Built Around Your Molecule?

Our R&D team will conduct a Paid Discovery Audit and build a proprietary clinical dossier for your specific active ingredient or therapeutic target. Full IP transfer included.

Discuss a Partnership → ← Return to Clinical Matrix